Cannell & Spears’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.3M Buy
26,404
+176
+0.7% +$68.5K 0.21% 98
2025
Q1
$11.4M Sell
26,228
-2,194
-8% -$954K 0.25% 91
2024
Q4
$10.5M Sell
28,422
-37,810
-57% -$13.9M 0.22% 98
2024
Q3
$34.4M Sell
66,232
-571
-0.9% -$297K 0.68% 51
2024
Q2
$36.2M Buy
66,803
+121
+0.2% +$65.6K 0.75% 43
2024
Q1
$34.6M Buy
66,682
+1,995
+3% +$1.03M 0.71% 45
2023
Q4
$30.5M Buy
64,687
+182
+0.3% +$85.8K 2.43% 15
2023
Q3
$28.1M Buy
64,505
+49
+0.1% +$21.3K 2.41% 16
2023
Q2
$28.6M Buy
64,456
+59,858
+1,302% +$26.6M 2.34% 15
2023
Q1
$2.11M Buy
+4,598
New +$2.11M 0.19% 60